Saturday, October 17, 2026 · Edition updated 6:00 AM ETSAT, OCT 17 · 6 AM ET editionNext edition in Next --:--:--

Do grape and wine compounds help the aging brain? A review of past studies

A summary of earlier studies · Nutrients · Oct 16, 2026

What this means

Researchers reviewed lab, animal, and human studies on grape and wine compounds and brain aging. They found the idea is plausible but human results are mixed. More studies are needed before any firm conclusions.

Plain-English summary written by an AI model from the abstract. The original is below.

Tested inSummary of earlier studies
Who it was tested in
A review of earlier studies, including cells, animals, and people
Kind of research
A summary of earlier studies

The science

Original title
Do Grape- and Wine-Derived (Poly)Phenols Contribute to the Hallmarks of Healthy Brain Ageing?
Authors
Ben Mohamed A, Vauzour D
Journal
Nutrients
Published
Oct 16, 2026
Study type
Review · in humans

Abstract

Population ageing is associated with a rising burden of cognitive decline, dementia and late-life affective disorders. Grape- and wine-derived (poly)phenols represent a chemically diverse group of bioactives whose biological relevance is shaped by structural complexity, the intervention matrix, host conjugation and gut microbial metabolism. Rather than acting as simple antioxidants, these compounds and their derived metabolites may influence interrelated pathways implicated in brain ageing, including neuroinflammation, endothelial function, synaptic plasticity, oxidative stress and gut-brain axis signalling. The gut microbiota is central to this framework as it converts poorly absorbed parent compounds into smaller phenolic metabolites and is modulated by (poly)phenol exposure. This review summarises the chemical and bioavailability features that determine intestinal and colonic availability, evaluates preclinical evidence concerning the neuroprotective potential of grape- and wine-derived (poly)phenols, and integrates clinical evidence from studies of cognitive ageing, mild cognitive impairment and Alzheimer's disease. Current evidence supports biological plausibility and justifies further investigation, but clinical findings remain heterogeneous. Future studies should prioritise chemically standardised preparations, metabolomic profiling, functional microbiome readouts, and integrated cognitive, vascular and inflammatory endpoints.

Read it on PubMed ↗

Ben Mohamed A, Vauzour D Do Grape- and Wine-Derived (Poly)Phenols Contribute to the Hallmarks of Healthy Brain Ageing?. Nutrients. 2026. doi:10.3390/nu18193144. PMID: 42884594. https://pubmed.ncbi.nlm.nih.gov/42884594/

Report a problem